CVS HEALTH CORPORATION Business Acquisition, Pro Forma Earnings Per Share, Diluted
CVS HEALTH CORPORATION (CVS) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of $0.88 per share for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2021-02-16
- CVS HEALTH CORPORATION business acquisition, pro forma earnings per share, diluted for the quarter ending 2018-03-31 was $1.39.
- CVS HEALTH CORPORATION business acquisition, pro forma earnings per share, diluted for fiscal 2018 was $0.88, a 83.11% decline from fiscal 2017.
- CVS HEALTH CORPORATION business acquisition, pro forma earnings per share, diluted for fiscal 2017 was $5.21.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|
| 2018-12-31 | $0.88 10-K · filed 2021-02-16 | $0.86 10-K · filed 2019-02-28 | |
| 2018-03-31 | $1.39 10-Q · filed 2019-05-01 | ||
| 2017-12-31 | $5.21 10-K · filed 2020-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |